Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

NCT00453986 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1352

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Meningococcal vaccine GSK134612
BIOLOGICAL: Mencevax™ACWY
BIOLOGICAL: Fluarix™

Sponsor

GlaxoSmithKline